Sarissa Capital Management as of March 31, 2019
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 19.1 | $127M | 868k | 146.41 | |
| Biogen Idec (BIIB) | 18.7 | $124M | 525k | 236.38 | |
| Ironwood Pharmaceuticals (IRWD) | 15.4 | $102M | 7.5M | 13.53 | |
| Medicines Company | 15.3 | $102M | 3.6M | 27.95 | |
| Innoviva (INVA) | 12.7 | $85M | 6.0M | 14.03 | |
| Puma Biotechnology (PBYI) | 8.3 | $55M | 1.4M | 38.79 | |
| Intercept Pharmaceuticals In | 5.4 | $36M | 320k | 111.86 | |
| Mersana Therapeutics (MRSN) | 3.0 | $20M | 3.8M | 5.26 | |
| Jazz Pharmaceuticals (JAZZ) | 2.1 | $14M | 100k | 142.95 | |
| Abbvie (ABBV) | 0.0 | $80k | 1.0k | 80.00 | |
| Mirati Therapeutics | 0.0 | $73k | 1.0k | 73.00 |
